• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Chemical Engineering
  • All Events
  • Seminars
  • Contact Us
  • Giving
  • About
    • Mission, Vision and Values
    • ChE Advisory Board
    • Diversity, Equity and Inclusion
    • Reporting Concerns and Misconduct
    • Faculty Search
    • Contact Us
  • News
  • Research
    • Research Areas
      • Biomolecular Engineering
      • Catalysis and Reaction
      • Cellular Engineering
      • Computing and Simulation
      • Materials
      • Microfabricated Systems
      • Nanotechnology
      • Polymers and Complex Fluids
      • Sustainable Energy
    • Facilities
    • Research Programs for Undergraduates
    • Partners in Industry
  • People
    • Administration
    • All Faculty
    • Core Faculty
    • Doctoral Students
    • Master’s Students
    • Postdoctoral Research Fellows
    • Staff
  • Graduate
    • Program
      • Graduate Degree Requirements
      • SUGS
      • Additional Options
      • Doctoral Candidacy Exam
      • Thesis Proposal Exam
      • Doctoral Committee
    • Prospective Students
      • Admissions Requirements
      • Admissions Timeline
      • TOEFL and GRE
      • Financial Support
      • Recruitment
      • Frequently Asked Questions
    • Current Students
      • Diversity, Equity and Inclusion
      • GSI Positions
      • Curricular Practical Training for F-1 Students
      • ChE Graduate Student Committee
    • Graduate Contacts
    • Why Michigan?
    • Housing
  • Undergraduate
    • Program
      • Mission
      • Incorporating Outreach
      • Program Improvement
      • Enrollment Data
    • Join Chemical Engineering
    • Degree Requirements
      • Intellectual Breadth
      • Courses & Course Profiles
    • Minors, Concentrations and Specialized Studies
    • Dual and Combined Degrees
    • Masters and SUGS Programs
    • Jobs and Research
      • Cooperative Education
    • Student Resources
      • Funding for Travel
      • Scholarships
      • Frequently Asked Questions
    • Student Groups
      • Funding for Groups
    • Undergraduate Contacts
  • Alumni
    • Stay Connected
    • Get Involved
    • Giving
    • Recruit Talent
    • Alumni Profiles
    • All Events
    • Seminars
    • Contact Us
    • Giving

New protein engineering method could accelerate the discovery of COVID-19 therapeutics

The method could one day be used to develop nanobodies against other viruses and disease targets as well.

Written by: Michigan Engineering

June 24, 2021

image of Peter TessierPeter M. Tessier
Albert M. Mattocks Professor of Pharmaceutical Sciences and Chemical Engineering

EXPERTS:

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

To that end, University of Michigan researchers found a simple method for identifying nanobodies with drug-like properties suitable for preventing SARS-CoV-2 infections. They demonstrated the approach by generating nanobodies that neutralized the SARS-CoV-2 virus more potently than an antibody isolated from an infected patient and a nanobody isolated from an immunized animal.

Nanobodies are small antibody fragments which bind strongly to their target molecules and block their functions. Currently, antibody and nanobody discovery involves selecting initial lead antibody candidates, followed by time- and labor-intensive modifications to make them suitable for therapeutic applications, said Jennifer Zupancic, doctoral candidate in chemical engineering and co-first author, with Alec Desai, doctoral candidate in chemical engineering. The study is in Cell Chemical Biology.

“A key advantage to this method, both in terms of addressing pandemics and nanobody development more generally, is the ability to select nanobodies that bind strongly more rapidly than with current methods,” said Zupancic.

“This unexpected discovery appears to be a key step toward addressing a long-standing challenge in the field, namely the rapid and simple generation of high-affinity agents (agents that bind strongly) such as nanobodies, without the need for extensive screening and optimization,” said Peter Tessier, the Albert M. Mattocks Professor in Pharmaceutical Sciences and Chemical Engineering, and senior author. He’s also a member of the U-M Biointerfaces Institute.

Passive immunization with nanobodies: two neutralizing nanobodies that target the receptor-binding domain of the SARS-CoV-2 spike protein. Nanobodies can have a highly increased neutralizing activity compared to antibodies. Source: PDB entry: 7b18. Koenig, P.A. et al. (2021) Science 371. Image credit: selvanegra, iStock

Nanobodies and antibodies bind to their targets via multiple flexible binding loops called the complementarity-determining regions. Researchers discovered that one or more of the individual binding loops from different lead nanobodies could be combined into single nanobody mutants with improved properties, Zupancic said. That process is called complementarity-determining region swapping.

“This process of CDR swapping resulted in substantial changes to the nanobodies we initially started out to modify,” she said. “It was surprising to us that such large changes not only did not hinder the nanobodies’ ability to bind and neutralize the SARS-CoV-2 virus, but actually greatly improved it.”

Researchers discovered the method accidentally, but found and reported that the technique is simple to perform in a systematic manner.

Generally, approved antibody drugs must demonstrate drug-like properties, including high stability, specificity and solubility, and must also bind strongly to their target. Often, there are tradeoffs between these properties, which frustrate therapeutic antibody development.

“However, we observe that our nanobodies have drug-like properties and also bind to and neutralize the SARS-CoV-2 virus strongly,” she said.

The new method likely can be used to develop nanobodies against other viruses and disease targets. That work is ongoing in the lab now, Zupancic said.

Explore: Biointerfaces Institute Biomolecular Engineering Chemical Engineering Health Peter Tessier

Footer

  • All Events
  • Seminars
  • Contact Us
  • Giving
  • Michigan Engineering
  • Strategic Vision
  • Graduate and Professional
  • Undergraduate
  • Michigan Engineering Research News

  • Facebook
  • LinkedIn
  • Twitter

© 2023 The Regents of the University of Michigan Ann Arbor, MI 48109 USA Privacy Policy | Non-Discrimination Policy | Campus Safety